Podcasts about treatments

A new mRNA vaccine for melanoma is making headlines. Moderna and Merck recently announced results from their clinical trial suggesting that this new vaccine, in combination with the cancer drug Keytruda, reduced recurrence rates in patients. The companies have not yet released full data from the trial. So, how does the vaccine work? And does this mark the beginning of a new era of cancer treatments using mRNA vaccine technology? Ira talks with physician Michael Postow, whose patients were part of the drug trial at Memorial Sloan Kettering Cancer Center. Guest: Dr. Michael Postow is chief of the melanoma service at Memorial Sloan Kettering Cancer Center. Transcript will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

For years, I quietly dealt with painful Hidradenitis Suppurativa until a surprising conversation with a friend told me how laser hair removal was a gamechanger for her HS. I was skeptical, but it ultimately became the HS treatment that made the biggest difference in my flares.In this episode, I'm sharing my experience with this treatment, who is most likely to benefit, types of lasers that work best, and how to possibly get this covered by your insurance. While this isn't a “root cause” fix for HS, it certainly can bring you relief if you're the right candidate for it, AND what you can do to then get at what's driving all that inflammation in the first place!⭐️Mentioned in This Episode:- See all the references + the HS laser hair removal insurance request form

More than half of diagnosed dental treatment walks out the door unscheduled. Most practices respond to low case acceptance by buying more new patients instead of fixing the leak. In this episode, Peter brings a 5-point fix for the treatment you've already diagnosed, from your treatment plan follow-up protocol to reducing friction to owning the money conversation. The through line: your software builds the list, but a personal text or 30-second video from the doctor beats every generic patient reactivation campaign. The practices that win are the ones willing to do what feels uncomfortable. The work is already diagnosed. Go get it!

Dr. Aaron Zelikovich talks with Dr. Bhaskar Roy about the latest treatments for myasthenia gravis, comparing their efficacy and safety.  Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Dr. Aaron Zelikovich talks with Dr. Bhaskar Roy about the latest treatments for myasthenia gravis, comparing their efficacy and safety.  Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Send us Fan MailSteroids again? This time in the eye. Daphna brings the DROP-ROP trial from JAMA Pediatrics, a double-masked randomized study across fourteen Swedish centers asking whether topical dexamethasone can stop pre-threshold ROP from progressing to type one disease. One hundred infants, born under 30 weeks, dosed for up to twelve weeks, some still getting drops at home. Twenty percent needed laser or anti-VEGF in the dexamethasone arm versus thirty-eight percent on placebo, a relative risk reduction that did not reach significance. Ben and Daphna talk through the safety signals, the intraocular pressure question, and how fast our field adopts promising ROP data.----Dexamethasone Eye Drops to Prevent Treatment-Requiring Retinopathy of Prematurity: The DROPROP Randomized Clinical Trial. Hellström A, Petrishka-Lozenska M, Sjöbom U, Wallander J, Nilsson AK, Löfqvist C, Ley D, Gränse L, Öhnell HM, Hård AL, Jakobsson G, Sävman K, Domellöf M, Löfgren S, Larsson E, Smith LEH, Pivodic A, Lundgren P; DROPROP Collaboration Group.JAMA Pediatr. 2026 Aug 3:e263247. doi: 10.1001/jamapediatrics.2026.3247. Online ahead of print.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

Hello sports fans and welcome back to another week and episode of Trudge Report. Thank you for being with us and thank you for your support. This week the dynamic duo of Greg and Shawn have the run of the place. Corey is cow tipping somewhere and Dan is dealing with some family stuff so special shout out and prayers to him and his family. The two of us go around the horn, giving some quick life updates, and Labor Day plans. Greg keeps us apprised of his still far away but coming up fast wedding next summer. We have a little MLB discussion as we approach the last month of the regular season before the playoffs. In the recovery segment we bring back the mini deep dive into different recovery programs. This week we delve into Refuge Recovery. This was the first and main offshoot of the Buddhist style recovery that we covered a few weeks ago. Refuge Recovery is a mindfulness-based addiction recovery program founded by Buddhist teacher and author Noah Levine. It serves as a non-theistic alternative to traditional 12-step programs. The history of it is packed with success, controversy, legal implications, and more. Enjoy. "Better than a thousand hollow words, is one word that brings peace." — DhammapadaDon't forget to like, share, rate, and download the podcast on all of your listening platforms. Check out and subscribe to our YouTube channel, @trudgrereportpod, for other content surrounding sports and trending topics. Trudge on good people. Contact the Guys:Instagram: @trudgereportpodFacebook: Trudge ReportTikTok: trudgereportpodYouTube: @trudgereportpod 

This week on The PQI Podcast, we are joined by Pat Garcia-Gonzalez, Co-founder and CEO of The Max Foundation. Founded in 1997 in honor of Pat's stepson, Maximiliano “Max” Rivarola, The Max Foundation has grown into a global organization focused on accelerating health equity and helping patients access cancer treatment and care. Today, the foundation works in more than 80 low- and middle-income countries and channels more than 10 million doses of cancer medications to patients each year. Pat joins us to share Max's story, how the foundation has evolved over nearly three decades, and the challenges patients around the world continue to face in accessing diagnostics, medications, and cancer care. We also discuss the importance of global partnerships, patient advocacy, and creating sustainable pathways to treatment. Learn more about The Max Foundation.

About one in five Australian men will be diagnosed with prostate cancer in their lifetime. Understanding the prostate, your risk and the options for testing can help with early detection and treatment. In this episode of Australia Explained, learn about prostate cancer, PSA testing, treatment and support. - 前列腺是位于膀胱下方的一个小腺体，是男性生殖系统的一部分。 随着男性年龄的增长，前列腺通常会发生变化。其中许多变化是良性的，但有些变化可能是癌症引起的。 大约五分之一的澳大利亚男性一生中会被诊断出患有前列腺癌。 前列腺癌早期很少出现症状。因此，了解自身风险、何时需要进行检查以及与医生讨论治疗方案至关重要。 以下是您需要了解的有关前列腺癌的检测和管理的信息。 点击音频收听详细报道

Send us Fan MailIf you've spent thousands of dollars on SIBO testing, antibiotics, herbal antimicrobials, supplements, restrictive diets, and practitioner visits but still aren't getting lasting relief, the problem may not be that you haven't tried hard enough. After more than a decade working with difficult SIBO cases, I've seen how easily digestive care can become fragmented: one test, one protocol, one diet, one supplement, without a larger strategy connecting them. In this episode, we're looking at what can be missing when SIBO treatment provides only temporary improvement, why treatment sequencing matters, and why a positive SIBO test doesn't tell you everything you need to know about the next step.We'll explore:Why repeatedly adding treatments isn't necessarily the answer. How your SIBO type can influence the treatment approach. Why the timing and sequencing of treatment matter. What your previous treatment history can reveal about what may have been missed. Why addressing root contributors matters when you're trying to reduce recurrence.What needs to happen beyond simply clearing an overgrowth. Why rebuilding the gut and expanding your diet can be an important part of the bigger picture. What to ask before spending money on another SIBO test, supplement, or protocol. Resources mentioned:1. Listen to: Root Causes of SIBO: Why It's Usually a Gut Environment Problem, Not Just a Bacteria Problem2. Listen to: Why SIBO Comes Back After Rifaximin  (3 Reasons Symptoms Return After Antibiotics)3. Listen to: SIBO Die-Off: Why You Feel Worse Before You Feel Better (And What To Do About It)4. If you've been stuck on a Low FODMAP diet and aren't sure what comes next, this free masterclass walks you through the five-step framework we use to help clients move beyond symptom management, rebuild food tolerance, and create a healthier, more resilient gut. 5. Still relying on a highly restricted diet to keep symptoms under control? Book a 1:1 Strategy Call and we'll look at your symptom history, what you've already tried, and whether working together makes sense, along with what that would look like. 6. Learn more about Nutrition Resolution's Signature Healthy Gut Restoration Program — a personalized, root-cause approach to addressing bloating, constipation, and underlying digestive imbalances.7. Follow Alyssa on: Instagram, LinkedIn, Facebook, Pinterest  -Looking for a supportive Gut Health community? Alyssa is building a community committed to helping people overcome their digestive symptoms by addressing the root cause using food and nutrition. Join Alyssa's FREE Facebook Community here.Tune in and subscribe to "The Gut Health Dialogues" for inspiring client transformation stories and expert insights into gut health. Leave a review. Your support will help Alyssa empower more people with the knowledge and tools to take control of their gut health and reclaim their lives. 

Send us Fan MailA police officer who becomes a therapist sounds like a plot twist, but it's also a rare window into what first responder mental health really needs. We're joined by Dana DeLorenzo, a retired transit police officer and now licensed mental health counselor, and we get honest about how the work changes you. Not the dramatic moments the public sees, but the daily accumulation: the stress, the cynicism that creeps in, and the reflex to say “I'm fine” even when you're not.We talk about Dana's path through dispatch, university policing, and years in transit, and why dispatchers are often the most overlooked part of the public safety system. The calls are frantic, the information has to be translated instantly, and the lack of closure can stick for years. We also dig into why so many first responders reject recognition, feel uncomfortable with the word “hero,” and minimize service even when the job clearly asks for sacrifice.From there, we zoom out to the deeper drivers: ACEs (adverse childhood experiences), unresolved trauma, PTSD versus “post-traumatic stress” language, and why naming symptoms can be the first step toward healing. We explore the idea that people rarely break from the first hard call, but from the 27th one they never processed, plus how concepts like complex PTSD and EMDR's “little T” and “big T” framework can help make sense of it. To Reach Dana, go to her LinkedIn account at this address: https://www.linkedin.com/in/dana-delorenzo-84916a379?utm_source=share_via&utm_content=profile&utm_medium=member_androidYou can email her at: mailto:ddelorenzo@firstrespondersix.comIf this conversation hits home, subscribe, share it with someone on your shift, and leave a review so more first responders can find support sooner rather than later.Support the showYouTube Channel For The Podcast

That split second after a patient asks “Can't you just fill it?” can quietly decide the whole case. If you hesitate, even with good intentions, you can accidentally turn your best clinical recommendation into an “upgrade” and make the compromised option feel like the default. We dig into why that happens and how to communicate treatment plans with calm confidence, so your patients feel informed instead of sold. We unpack the difference between what you technically could do and what you would actually recommend, using a simple analogy that makes the point stick. From crown vs filling conversations to new patient exams, we talk about the trap of negotiating against your own diagnosis, and why trying to keep everyone happy can chip away at your authority, your case acceptance, and your enjoyment of dentistry. We also get practical about objections. “Just a filling” is often a placeholder for something else: fear, mistrust, confusion, low perceived value, or money. You'll hear how to stop diagnosing the patient's wallet, ask better questions, and give real patient autonomy by presenting the ideal plan clearly, then letting them choose with full understanding of risks, benefits, and alternatives. If you want better communication, stronger trust, and a practice that runs smoother without you feeling slimy, this is for you. Subscribe for more dentistry practice management strategies, share this with a dentist who needs it, and leave a quick review so more practice owners can find the show.Join Us at our Upcoming Retreat October 2nd and 3rd.  Click Here to Register If you are ready to increase your new patients and start growing your practice, visit www.relevanceonlinemarketing.com and see what you've been missing with your current company. Take Control of Your Practice and Your LifeWe help dentists take more time off while making more money through systematization, team empowerment, and creating leadership teams.Ready to build a practice that works for you? Visit www.DentalPracticeHeroes.com to learn more.

Millions of people around the world suffer from gastrointestinal issues like gastroparesis, reflux, and constipation, but until now, the available treatments haven't been very effective, and often carry some pretty nasty potential side effects. Today, we're featuring a company hoping to bring those people relief with a drug that's both efficacious and safe. Today's guest is Peter Milner, the founder and managing member of Renexxion, where he serves as the CEO of its wholly owned operating subsidiary, Renexxion Ireland Limited, a clinical stage biopharma company committed to delivering innovative drugs to patients with gastrointestinal disorders globally. Peter's a board-certified cardiologist, a physician-scientist and a serial entrepreneur with a proven track record of building successful biotechnology companies, including CV Therapeutics and Aptivio Biotechnology, and advancing novel therapeutics from discovery to development. Today, Peter's going to walk us through Renexxion's very promising new drug, the treatment gap it aims to redress, and what it will take to get it through clinical trials and into the hands of patients. Highlights:From Medicine to Serial Entrepreneur (3:00)The Gap in GI Treatment (3:30)How the Drug Works (6:10)Where Others Failed (5:05)Trial Results and the Road to Phase 3 (8:20)The Problem with Current Treatments (9:45)The Dr. Falk Partnership (17:10)Pipeline in a Pill (20:20)The Billion-Dollar Opportunity (21:45)What's Next for Renexxion (23:50)Links:Peter Milner LinkedInRenexxion LinkedInRenexxion WebsiteICR LinkedInICR TwitterICR Website Feedback:If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, joe@lowerstreet.co

Send Zorba a message!Zorba looks a study about distracted driving, and how traffic fatalities surge on days when popular artists release new albums. He helps a caller whose health insurance soared after getting "advice" from his doc. Zorba helps a listener with HRT questions, talks about grief and human resiliency, Karl's mom shares a Mom Joke, and Zorba gets stumped on a boozy question.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck's individualized treatment for melanoma, after more than a decade of work on personalized cancer vaccines. Stéphane explains how the treatment works by sequencing an individual patient's tumor and healthy cells, identifying the mutations most relevant to their cancer, and encoding up to 34 of them into an mRNA designed specifically for that patient. Rather than simply unleashing the immune system, the goal is to teach it exactly what to recognize and attack. They also unpack the engineering challenge of manufacturing a different medicine for every patient, how Moderna has brought the process down to roughly 42 days from biopsy to treatment, and what it would take to manufacture personalized medicines at scale. Finally, Stéphane looks beyond melanoma to lung, kidney, bladder, pancreatic, and gastric cancers, as well as Moderna's longer-term work applying mRNA to rare genetic and autoimmune diseases. Resources: Follow Stéphane Bancel on LinkedIn: https://www.linkedin.com/in/st%C3%A9phane-bancel-8185251/ Follow Jorge Conde on X: https://x.com/JorgeCondeBio Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

On episode #114 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 8/18 – 8/31/26. Hosts: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral HPV Vaccination and Risk of Head and Neck Cancers: A Large Real-World Cohort Study (International Society for Infectious Diseases) Beyond the Acute Illness: Three Myths About Viral RespiratoryInfection (JID) Use of Nowcasting to Estimate Real-Time Transmission Trends During a Measles Outbreak — South Carolina, October 2025–March 202 (CDC: MMWR) IPOL (Package Insert) Effect of inactivated poliovirus vaccine on nasal mucosal immunity and pharyngeal shedding following novel oral poliovirus vaccine type 2 challenge: A randomized, open-label trial (JID) Bacterial Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis (NEJM) Clinical Practice Guidelines by Infectious Diseases Society of America 2025 Guidelines on Management and Treatment of Complicated Urinary Tract Infections–Introduction and Methods (CID) Society of America: 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections–Selection of Antibiotic Therapy for Complicated Urinary Tract Infections (CID) Clinical Practice Guidelines by Infectious Diseases Society of America: 2025 Guidelines on Management and Treatment of Complicated Urinary Tract Infections – Timing of Intravenous to Oral Antibiotics Transition for Complicated Urinary Tract Infections (CID) Clinical Practice Guidelines by Infectious Diseases Society of America (IDSA): 2025 Guidelines on Management and Treatment of Complicated Urinary Tract Infections–Duration of Antibiotics for Complicated UTI (CID) Infective Endocarditis in Solid Organ and Haematopoietic Stem Cell Transplant Recipients (E-IPA Study): a propensity-score-matched retrospective cohort study (CID) Evaluation of Changes in Staphylococcus and Enterococcus Resistance Following Reduced Restrictions on Daptomycin and Linezoli (OFID) Comparison of VPM1002 with BCG in the prevention of tuberculosis in newborn infants: a multicentre, double-blind, randomised, phase 3, non-inferiority trial (LANCET: Infectious Diseases) Fungal The Last of US Season 2 (YouTube) Containment of a Candidozyma auris Outbreak in an Acute Care Hospital using a Comprehensive Screening and Surveillance Program (CID) Molecular Evidence of Autochthonous Environmental Acquisition of Fonsecaea Pediatric Infection in the United States (OFID) Challenging the concept of uncomplicated candidemia for shorter courses of antifungal therapy (OFID) Parasitic Miscellaneous Reliability of Physical Examination Findings in Youths Diagnosed With Pneumonia (JAMA) Recombinant shingles vaccination and the risk of cardiovascular events (Nature Medicine) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

Learn more about Parkinson's and find support: https://dpf.org  In this episode of the Parkinson's Podcast, we welcome Dr. Abhi Mahajan and two retired physicians living with Parkinson's, Doug Redosh and Stan Livingston, for a discussion about what's missing in current Parkinson's treatments, how the next generation of treatments may help, and how people with Parkinson's might approach emerging treatments as they become available.   This episode is sponsored by AskBio.  Sign up for updates on webinars, events, and resources for the Parkinson's community: https://dpf.org/newsletter-signup  

Send Zorba a message!Zorba looks a study about distracted driving, and how traffic fatalities surge on days when popular artists release new albums. He helps a caller whose health insurance soared after getting "advice" from his doc. Zorba helps a listener with HRT questions, talks about grief and human resiliency, Karl's mom shares a Mom Joke, and Zorba gets stumped on a boozy question.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

About one in five Australian men will be diagnosed with prostate cancer in their lifetime. Understanding the prostate, your risk and the options for testing can help with early detection and treatment. In this episode of Australia Explained, learn about prostate cancer, PSA testing, treatment and support. - حدود یک پنجم مردان استرالیایی در طول زندگی خود به سرطان پروستات مبتلا می‌شوند. در مراحل اولیه، سرطان پروستات به ندرت علائمی ایجاد می‌کند. به همین دلیل درک خطر ابتلا، دانستن زمان مناسب برای آزمایش و صحبت با پزشک در مورد گزینه‌های درمانی دارای اهمیت است . در این قسمت از دریچه ای به استرالیا درباره آنچه باید در مورد تشخیص و مدیریت سرطان پروستات بدانید، صحبت میکنیم.

Cole Sikes, communications specialist at the Auburn University School of Forestry, Wildlife & Environment, visits with Nina Payne, research scientists with Auburn University and the Southern Forest Nursery Management Cooperative, about a developing technique to deal with nutsedge on pine plantations.Find out more about our sponsor, Alabama Ag Credit, and also about Alabama Farmers Federation. 

About one in five Australian men will be diagnosed with prostate cancer in their lifetime. Understanding the prostate, your risk and the options for testing can help with early detection and treatment. In this episode of Australia Explained, learn about prostate cancer, PSA testing, treatment and support. - На околу еден од пет австралиски мажи ќе им биде дијагностициран рак на простата во текот на животот. Што повеќе знаете за простатата, вашиот ризик и опциите за тестирање, може да помогне во раното откривање и лекување. Во оваа епизода од Australia Explained, дознајте за ракот на простата, тестирањето на PSA, лекувањето и поддршката.

In this episode of the Pumps & Systems podcast, we're speaking with Les Flynn from CAPE HydroTek, who is going to tell us about catalytic water treatment systems and what kinds of challenges that technology can help with. Tune in the first Wednesday of every month for new episodes of the podcast! Watch on YouTube: https://youtu.be/xmYrtQTSd2A?si=hsGA-RF-XBCr6fLt Pumps & Systems Podcast homepage: https://www.pumpsandsystems.com/podcast/ Pumps & Systems Magazine: http://www.pumpsandsystems.com Opening music: Know Myself - Patrick Patrikios Closing music: Freeling - Lauren Duski

In the final episode, Professor Maria Fleseriu and Professor Mônica Gadelha discuss the updated treatment algorithm, treatment sequencing, and management approaches for patients with resistant disease. This educational podcast series is intended for US healthcare professionals only. It was developed by expert faculty in collaboration with The Pituitary Society and Amiculum, with support from Recordati Rare Diseases through an independent educational grant. Recordati Rare Diseases had no involvement in content development, speaker selection, or editorial decisions. Discussions in this series are informed by the 2025 consensus on therapeutic outcomes in acromegaly (Melmed S et al. Nat Rev Endocrinol 2025;21:718–37). Speaker disclosures: Maria Fleseriu (Oregon Health and Science University, Portland, USA) Research grants to her university from Crinetics Pharmaceuticals and Debio.Scientific consulting fees from Crinetics Pharmaceuticals, Camurus AB, Marea and Recordati Rare Diseases. Mônica Gadelha (Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil) Advisory board member for Camurus AB, Crinetics Pharmaceuticals, Novo Nordisk and Recordati Rare Diseases. Research investigator for Crinetics Pharmaceuticals and Recordati Rare Diseases. Speaker for Camurus AB, Crinetics Pharmaceuticals, Novo Nordisk and Recordati Rare Diseases.

Interview with Joan Pellegrino, MD

In lieu of a traditional episode this week, we have something very special to share: the audio from Cat and Pat's one-night-only live show at Moth Club in London from June 1, 2026! Listen in as Cat and Pat give incredible advice, reenact a short scene featuring an interrogation at Lululemon, and marvel at the beauty of proclaiming I Am Me...Now. Note: We were only given one combined audio track from this performance (and no video), so if you're wondering why the audio quality is different, that's why! That being said, we think it's such a great show that we really wanted to share it with you anyways.Watch the full episode on our YouTube and follow below!Show Instagram: https://www.instagram.com/seektreatmentpodShow Tiktok: https://www.tiktok.com/@seektreatmentpodCat: https://www.instagram.com/catccohenPat: https://www.instagram.com/patreegsSeek Treatment is a production of Headgum Studios. Our producer is Allie Kahan. The show art was created by Carly Jean Andrews.Like the show? Rate Seek Treatment on Spotify and Apple Podcasts and leave a review.Advertise on Seek Treatment via Gumball.fmSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

When your child has OCD, treatment doesn't happen in a vacuum. OCD comes home with them. It impacts routines, relationships, school, behavior, and often the way the entire family functions.So why are parents sometimes left on the sidelines of OCD treatment?Parents can be one of the most powerful resources in a child's OCD recovery. You see what happens between therapy sessions, you're often the one navigating accommodations and difficult behaviors, and you're in a unique position to help your child practice the skills they're learning.In this week's episode of the AT Parenting Survival Podcast, I talk about what healthy parent involvement in OCD treatment can look like, what information you should have, when it makes sense for a therapist to protect your child's privacy, and some red flags that may indicate you're being left out more than you should be.I also talk about how this changes once your child turns 18 and how parents can continue to be a valuable source of support while respecting their adult child's privacy and autonomy.If you've ever wondered whether you're too involved, not involved enough, or whether you should be advocating for a bigger role in your child's treatment, this episode is for you.

My website My Instagram

Candida overgrowth may contribute to symptoms ranging from IBS and recurrent vaginitis to brain fog and chronic fatigue. Dean Mitchell, MD, author of "Conquering Candida", discusses how antibiotics, PPIs, stress and microbiome disruption can promote Candida overgrowth, as well as his approach to treatment using diet, antifungals, vitamin therapy and sublingual Candida immunotherapy. He also explores the limitations of Candida testing and the importance of restoring a diverse microbiome. Lindsey Parsons, your host, helps clients solve gut issues and reverse autoimmune disease naturally. Take her quiz to see which stool or functional medicine test will help you find out what's wrong. She's a Certified Health Coach at High Desert Health in Tucson, Arizona. She coaches clients locally and nationwide. You can also follow Lindsey on Facebook, Tiktok, Instagram, Pinterest, Mastodon or X, or reach her via email at lindsey@highdeserthealthcoaching.com to set up your free 30-minute Gut Healing Breakthrough Session. Show Notes

Description: Featuring a slide presentation and related discussion from Prof Ticiana Leal, including the following topics: ·      Incidence, pathophysiology and clinical presentation (0:00) ·      Diagnostic challenges and evaluation process (3:37) ·      Treatment modalities and therapeutic options (10:01) ·      Mechanistic effects and key clinical trial data for amifampridine (12:20) ·      Key takeaways and conclusions (17:32) CME information and select publications

We unpack a headline-making surrogacy dispute where a contract pressures a pregnancy termination, then trace how state-by-state abortion law creates conflict and confusion. We also weigh late-term abortion policy, organ transplant preservation, and AI-driven identity mimicry through a Christian pro-life lens that prioritizes both truth and compassion.SHOW NOTES:Rejected Surrogate Baby Must Get Treatment: A Texas court ordered immediate lifesaving treatment for Gabriel, born with hypoplastic left heart syndrome after his surrogate refused the intended California parents' request for an abortion. The ruling blocks delays, transfer, discharge, or removal while litigation continues, spotlighting conflicts over surrogacy, parental authority, disability, and medical decisions after birth.  (Source: https://tinyurl.com/2c83z4ka  accessed 8-13-26)Massachusetts Legalizes Abortion Until Birth: Massachusetts Governor Maura Healey signed House Bill 5595, replacing restrictions on abortions after 24 weeks with physician professional judgment. The law permits later abortions outside hospitals, removes certain oversight requirements, and limits insurer review. Supporters cite access during serious complications; opponents warn it eliminates protections for viable unborn children statewide. (Source: https://tinyurl.com/24terxbm  accessed 8-12-26)Efforts to Stockpile Human Organs for Transplant: Scientists are finding new ways to keep donor organs alive outside the body. Teams supercooled pig kidneys to minus 4 degrees Celsius for days, then reimplanted them successfully. Others use perfusion machines that pump nutrients into livers, kidneys, eyes, and even a human uterus, extending viability past 24 hours. Longer preservation could ease organ shortages and reshape transplant ethics and access.  (Source: https://tinyurl.com/24h6fdtn  access 7-29-26)Preserving Human Identity Artificially: Veterans First for America unveiled a quantum-powered project claiming digital DNA could preserve a person's identity in humanoid robots after death. A 40-sensor haptic suit would record movement, vital signs, and skills, building profiles licensed for up to 500 years. Experts still demand real validation before such claims earn trust.  (Source: https://tinyurl.com/2xlh4ukf  accessed 8-3-26)Support the showThe ministry of Christian Life Resources promotes the sanctity of life and reaches hearts with the Gospel. We invite you to learn more about the work we're doing: https://christianliferesources.com/When the world feels confusing, heavy, and loud, where do you find something solid to stand on? Rooted by the River is a one-day pro-life, Christian conference designed to anchor you in God's Word and equip you to face some of today's hardest issues. Don't miss presentations on coping, sexual shame, AI, and better conversations about abortion. Plus a powerful interview with an abortion survivor! You'll be strengthened to live and speak with courageous, Christ-centered hope right where God has placed you. Register today: https://christianliferesources.com/get-involved/events/2026-conference

Clinical Disclaimer: This episode is for educational purposes for licensed healthcare professionals and is not individual medical advice. Ketamine and esketamine are not FDA‑approved for preventing or treating postpartum depression; any use in this population is off‑label and should be considered investigational and undertaken only with appropriate training, collaboration, and adherence to current standards of care.Postpartum depression affects roughly 10 to 20 percent of mothers and remains one of the most undertreated conditions in medicine. As public awareness of maternal mental health grows, providers in the ketamine and psychedelic therapy space are increasingly asking: is there a role for ketamine or esketamine here?This episode is our evidence-based answer to that question.We walk through the current clinical literature on ketamine and esketamine for perinatal depression, drawing on randomized controlled trials, meta-analyses, and expert commentary from institutions including the Center for Women's Mental Health at Massachusetts General Hospital. The research landscape is more nuanced than most providers realize, and understanding it clearly matters both for patient conversations and for how you think about your practice's scope.One distinction shapes everything that follows in this episode, and it's an important one: virtually all of the existing trial data involves perioperative prevention in cesarean delivery populations, not outpatient treatment of established postpartum depression. Knowing what the evidence actually supports and where the gaps remain is essential context for any provider working in this space.What You'll Gain· A clear breakdown of what current ketamine and esketamine trials actually show for postpartum depression prevention, and what limited data exist for treatment.· An understanding of why racemic ketamine and esketamine tell different stories in the peripartum literature.· The key ethical and practical considerations for any provider thinking about this population.· An honest framework for how to talk with patients who ask about ketamine for postpartum depression.· Context on what the research gaps mean for where this field is heading.Review the research behind this episode, including full citations for every study discussed, in the Clinical References and Further Reading.

Hernias are common, but that doesn't mean they should be ignored. In the newest episode of Enloe Health's podcast Health Matters, James Partridge, M.D., from Enloe Health & Wellness General Surgery explains what hernias are, what causes them, and when it may be time to seek treatment. We also hear from patient Andrew Kinley, who lived with a hernia for years before pain began affecting his fitness goals. Kinley shares his experience with robotic hernia repair and how surgery helped him get back to the activities he enjoys.

About one in five Australian men will be diagnosed with prostate cancer in their lifetime. Understanding the prostate, your risk and the options for testing can help with early detection and treatment. In this episode of Australia Explained, learn about prostate cancer, PSA testing, treatment and support. - Khoảng 1 trong 5 nam giới tại Úc được chẩn đoán mắc ung thư tuyến tiền liệt trong suốt cuộc đời. Hiểu rõ về tuyến tiền liệt, các yếu tố nguy cơ và những lựa chọn xét nghiệm có thể giúp phát hiện bệnh sớm và điều trị kịp thời.

About one in five Australian men will be diagnosed with prostate cancer in their lifetime. Understanding the prostate, your risk and the options for testing can help with early detection and treatment. In this episode of Australia Explained, learn about prostate cancer, PSA testing, treatment and support. - يُشخَّص نحو رجل من بين خمسة رجال في أستراليا بسرطان البروستاتا خلال حياته. لذلك فإن فهم طبيعة البروستاتا، ومعرفة عوامل الخطورة، والإلمام بخيارات الفحص المتاحة، كلها أمور يمكن أن تسهم في الكشف المبكر عن المرض وبدء العلاج في الوقت المناسب. وضرورة معرفة سرطان البروستاتا، وفحص المستضد النوعي للبروستاتا (PSA)، وخيارات العلاج، وسبل الدعم المتاحة.

Transforming your health is more fun with friends! Join Chef AJ's Exclusive Plant-Based Community. Become part of the inner circle and start simplifying plant-based living - with easy recipes and expert health guidance. Find out more by visiting: https://community.chefaj.com/ ORDER MY NEW BOOK SWEET INDULGENCE!!! https://www.amazon.com/Chef-AJs-Sweet-Indulgence-Guilt-Free/dp/1570674248 or https://www.barnesandnoble.com/w/book/1144514092?ean=9781570674242 GET MY FREE INSTANT POT COOKBOOK: https://www.chefaj.com/instant-pot-download MY BEST SELLING WEIGHT LOSS BOOK: https://www.amazon.com/dp/1570674086?tag=onamzchefajsh-20&linkCode=ssc&creativeASIN=1570674086&asc_item-id=amzn1.ideas.1GNPDCAG4A86S Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. Watch TrueHealth TV for FREE: https://www.healthpromoting.com/tnhtv Please get the book here now! To get a copy signed by Dr. Goldhamer: https://www.healthpromoting.com/can-fasting-save-your-life To buy on Amazon: https://www.amazon.com/dp/1570674191?linkCode=ssc&tag=onamzchefajsh-20&creativeASIN=1570674191&asc_item-id=amzn1.ideas.1GNPDCAG4A86S&ref_=aip_sf_list_spv_ofs_mixed_d_asin Dr. LIsle and Dr. Goldhamer's book The Pleasure Trap: https://www.amazon.com/dp/1570671974?tag=onamzchefajsh-20&linkCode=ssc&creativeASIN=1570671974&asc_item-id=amzn1.ideas.1GNPDCAG4A86S Dr. Alan Goldhamer is the co-founder of TrueNorth Health Center, a state-of-the-art facility that provides medical and chiropractic services, psychotherapy and counseling, as well as massage and bodywork. He is also director of the Center's groundbreaking residential health education program. Dr. Goldhamer has supervised the fasts of thousands of patients. Under his guidance, the Center has become one of the premier training facilities for doctors wishing to gain certification in the supervision of therapeutic fasting. Dr. Goldhamer was the principal investigator in two landmark studies. The first: "Medically Supervised Water-Only Fasting in the Treatment of Hypertension" appeared in the June 2001 issue of the Journal of Manipulative and Physiological Therapeutics. Its publication marked a turning point in the evolution of evidence supporting the benefits of water-only fasting. The second study: "Medically Supervised Water-Only Fasting in the Treatment of Borderline Hypertension," appeared in the October 2002 issue of the Journal of Alternative and Complementary Medicine. Currently, Dr. Goldhamer is directing a team that is developing a prospective study, incorporating random assignment and long-term follow-up on the cost and clinical outcomes in the treatment of diabetes and high blood pressure with fasting and a health-promoting diet. After completing his chiropractic education at Western States Chiropractic College in Portland, Oregon, Dr. Goldhamer traveled to Australia, where he became licensed as an osteopathic physician. He is the author of The Health Promoting Cookbook and co-author of The Pleasure Trap: Mastering The Hidden Force That Undermines Health and Happiness. Dr. Goldhamer is speaking at the NHA Virtual Conference (June 27-30, 2024). Use this link to get your tickets now: https://events.ringcentral.com/events/nha-conference-2024/registration?utm_campaign=Chef+AJ&utm_source=Affiliate For coaching services: https://www.healthpromoting.com/clinic-services/health-services/coaching-services To register for a stay at TrueNorth: https://www.healthpromoting.com/registration

Please visit answersincme.com/JKK860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Alison J. Birtle, FRCP, FRCR, MD; and Niklas Klümper, MD. In this activity, experts in oncology discuss systemic therapies for locally advanced and metastatic urothelial carcinoma. Upon completion of this activity, participants should be better able to: Assess the evidence for recommended systemic treatment regimens for patients with LA/mUC in the context of treatment guidelines; Propose appropriate patient assessment strategies to guide systemic therapy decisions; and Formulate individualized treatment strategies to optimize outcomes for patients with LA/mUC using recommended first-line systemic treatments.

About one in five Australian men will be diagnosed with prostate cancer in their lifetime. Understanding the prostate, your risk and the options for testing can help with early detection and treatment. In this episode of Australia Explained, learn about prostate cancer, PSA testing, treatment and support. - ประมาณหนึ่งในห้าของผู้ชายชาวออสเตรเลียจะได้รับการวินิจฉัยว่าเป็นมะเร็งต่อมลูกหมากในช่วงชีวิตของพวกเขา การทำความเข้าใจเกี่ยวกับต่อมลูกหมาก ความเสี่ยง และทางเลือกในการตรวจ สามารถช่วยในการตรวจพบและรักษาได้ตั้งแต่เนิ่นๆ รายการ Australia Explained สัปดาห์นี้ เราจะเรียนรู้เกี่ยวกับมะเร็งต่อมลูกหมาก การตรวจ PSA การรักษา และการสนับสนุน

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Brian Grosberg is a world-renowned headache specialist who joins Peter to provide a master class on the diagnosis and treatment of headache disorders. In this episode, Brian explains the distinction between primary and secondary headaches and breaks down the defining features of the "big three" primary headache types (migraine, cluster, and tension headache)—highlighting how often they are misdiagnosed and how they are treated. He explores the epidemiology of headaches, describing migraine as an invisible disease affecting about 12% of the population, disproportionately affecting women, while cluster headaches more often affect men. He discusses the major gap between demand for headache care and available specialists, and he offers advice on when to see a physician. Brian dives into the multifactorial nature and pathophysiology of migraine, including genetic and hormonal influences, neurovascular changes, and inflammatory signaling, and connects these mechanisms to modern therapies. Throughout the conversation, he emphasizes the individualized nature of headache disorders and the importance of a detailed headache diary. Brian shares practical strategies for treating headaches including lifestyle changes, medications, and neuromodulation devices. We discuss: Brian's interest in headaches and how Peter met Brian [2:15]; Differentiating the types of headaches: primary versus secondary headache and tension versus migraine headache [7:30]; The epidemiology and burden of migraine, its disproportionate affect on women, and the shortage of headache specialists [20:00]; Genetic susceptibility to migraine and the role of hormones [24:45]; Migraine triggers, the impact of hormones, and the importance of a headache diary [31:15]; The phases of a migraine: premonitory symptoms, aura, the headache itself, and the postdrome [38:15]; Tension headaches: symptoms, causes, and prevalence [41:45]; Cluster headaches: extreme pain, distinctive symptoms, and frequent misdiagnosis as a sinus infection or allergies [43:15]; Lifestyle interventions to prevent headaches [51:15]; Pharmacological treatments to prevent headaches [1:05:00]; What's known about the pathophysiology of migraines: neurovascular changes, release of neuropeptides, and inflammatory response [1:14:45]; CGRP antagonists for the treatment of migraines: large monoclonal antibodies and gepants [1:20:15]; Use of calcium channel blockers and Botox to treat cluster headache and migraine [1:28:30]; Drugs for the acute treatment of migraines [1:32:30]; Treatment of migraines with electrical stimulation devices [1:40:00]; Use of THC or cannabis to treat headaches [1:44:00]; What Brian wants people to know about headaches [1:45:45]; Brian's advice on when to see a doctor about headaches and how to prepare for that visit [1:49:15]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Test your knowledge of AKI with this quick set of audio flashcards. Dive right in or brush up on your nursing knowledge of AKI first, in episode #509: Acute Kidney Injury for Nursing Students: Causes, Symptoms, Labs & Treatment. These mini-reviews are a great way to study on the go, and they give you a taste of what it's like inside Study Sesh, my audio study tool for busy nursing students.

The New York Times best-selling author's new memoir, Crying in the Bathroom, dives deep into mental illness, desire, “life and death” decisions and the power of creating the life you are worthy of. Follow Erika on Instagram @erikalsanchez. If you loved this episode, listen to Julissa Natzely Arce Raya Wants You to Reclaim Your Identity and Why Novelist Xochitl Gonzalez Isn't Done Being Ambitious. Show your love and become a Latina to Latina Patreon supporter! This episode is sponsored by MAUI MOISTURE®. All of MAUI MOISTURE® vegan haircare products are made with 100% Aloe Vera as the first ingredient to hydrate hair across the curl spectrum. They have everything you need for wash day and general upkeep; Shampoos and Conditioners, Treatments, Oils, and Stylers that leave hair flake-free with no residue! For a limited time, Latina to Latina listeners get 15% off select MAUI MOISTURE® products on Amazon. Buy your new favorite hair products and take advantage of the special offer only open to our listeners. Just visit the link created for our show: tiny.cc/mauimoisture Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr. Mohammad Ashori is a board-certified family medicine physician, health coach, and rock climber. We talked about the importance of putting on muscle, how much rest we need between training sessions, nutrition and metabolic health, zone 2 cardio, key metrics and blood markers to track, different levels of data, why some data can be misleading or harmful, relative vs. absolute risk, and much more. Want to work with Dr. Ashori? Get 15% off your 1st health assessment with Dr. Ashori. Book your schedule here and use the code: NUGGET15 Want climbing or nutrition coaching? Free Masterclass (Learn more about Climb Accelerator)

Dr. Donn Posner is a leading expert in Cognitive Behavioral Therapy for Insomnia (CBT-I), founder and president of Sleepwell Consultants, and an adjunct clinical associate professor in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. He is co-author of Cognitive Behavioral Therapy for Insomnia: A Session-by-Session Guide, and he has trained and consulted with clinicians nationally and internationally across nearly four decades of clinical practice. In this second of two episodes, the conversation turns from what CBT-I is to how clinicians actually learn and deliver it. Dr. Posner reviews the available training pathways and what proficiency really requires, and explains why sleep hygiene — the advice most patients have already heard many times over — does not treat chronic insomnia, even though it has a place later in the work. He identifies the high-yield principles any clinician can apply immediately, including a fixed morning wake time, early light exposure, and getting out of bed when not sleeping. He then examines sleep effort as a perpetuating factor and CBT-I as fundamentally a therapy of acceptance, describing how he prepares patients for a treatment that will make them feel worse before it makes them better, and how cognitive work addresses the fear and resistance that follow. He closes with what clinicians should expect from a course of treatment — typical length and spacing, responder and remitter outcomes, and the durability of gains — along with how he handles sleep medication and why guidelines place CBT-I ahead of hypnotics.Learning ObjectivesAfter completing this educational activity, participants should be able to:Explain why sleep hygiene is ineffective as a monotherapy for chronic insomnia, and describe the more limited role it plays within a full course of CBT-I.Identify high-yield behavioral sleep medicine principles — including a fixed morning wake time, early light exposure, and getting out of bed when not sleeping — that clinicians can apply before completing formal CBT-I training.Describe sleep effort as a perpetuating factor, and summarize how the cognitive and acceptance-based components of CBT-I address the dysfunctional beliefs and resistance that arise during treatment.Summarize the expected course and outcomes of CBT-I (including typical session number and spacing, responder and remitter outcomes, and durability of gains) and explain why guidelines position CBT-I ahead of hypnotic medication.Topics Covered in This InterviewPathways to training in CBT-I and behavioral sleep medicineBoard certification in behavioral sleep medicineWhy sleep hygiene alone does not treat chronic insomnia: the dental hygiene analogyWhere sleep hygiene does belong within CBT-IAvailable CBT-I training programs and online optionsHow clinicians become proficient: consultation, community, and case experienceHigh-yield behavioral sleep principles any clinician can applySleep regularity, fixed wake times, and morning light exposureWhy getting out of bed is the hardest intervention for patients to acceptSleep effort as a perpetuating factorWhat good sleepers do — and do not do — to fall asleepCBT-I as a therapy of acceptancePreparing patients for the work: “I'm going to make you worse before I make you better”The cognitive component: uncovering and debunking dysfunctional beliefsCommon patterns of resistance, and exposure as the remedyTypical treatment length, session spacing, and pacingResponders versus remitters, and what the outcome data showDurability of gains and the role of sleep self-efficacyManaging and tapering sleep medication alongside CBT-IWhy guidelines position CBT-I ahead of hypnotic medication

Implants can significantly improve a patient's quality of life, but how do we sell patients on an expensive, elective purchase? Today on Everyday Oral Surgery, Dr. Grant Stucki is joined once again by Dr. Roger Levin to start a new series on the Implant Treatment Coordinator (ITC). Tuning in, you'll hear all about why implant cases cannot be presented in a passive way, why having a trained, sales-oriented ITC is beneficial, the kinds of skills an ITC needs, why ITCs need a training overhaul, and more! We delve into the four main reasons dental surgeons need to have an ITC before discussing what the right ITC can do for dental surgeons. Dr. Levin also talks about when surgeons should bring in an ITC. Finally, we touch on what listeners can expect from the next few episodes in this series. Thanks for listening!Key Points From This Episode:Welcoming Dr. Roger Levin back to the show.An introduction to our new series: the Implant Treatment Coordinator.Why implant presentations need to be more sophisticated.The importance of having a dedicated ITC and the skills they need.A breakdown of the four main reasons dental surgeons need an ITC.What the right ITC can do for a dental surgeon and their practice.When a dental surgeon should bring in an ITC (the earlier, the better!)Links Mentioned in Today's Episode:Dr. Roger Levin on LinkedIn — https://www.linkedin.com/in/roger-levin-69ab744/ Dr. Roger Levin Email — rlevinconf@levingroup.com Levin Group — https://levingroup.com/ Everyday Oral Surgery Website — https://www.everydayoralsurgery.com/ Everyday Oral Surgery on Instagram — https://www.instagram.com/everydayoralsurgery/ Everyday Oral Surgery on Facebook — https://www.facebook.com/EverydayOralSurgery/Dr. Grant Stucki Email — grantstucki@gmail.comDr. Grant Stucki Phone — 720-441-6059

If patients leave unsure about the plan, treatment acceptance has already started slipping. In this Monday Marketing Move, Dr. Sachin Soni breaks down one of the most overlooked moments in the treatment conversation: making a clear recommendation, then giving the patient space to respond honestly. Instead of asking narrow questions like “Do you want to go ahead?” he suggests using more human language like, “So tell me, what are your thoughts?” to uncover hesitation around cost, fear, pain, or timing while the patient is still in front of you. He also shares how dentists can confirm true understanding by creating a partnership where patients know exactly what treatment is being done, why it matters, what it costs, and what to expect at each appointment.What You'll Learn in This Episode:Why unclear recommendations quietly lower treatment acceptanceThe simple phrase that opens up better patient conversationsHow to check whether patients truly understand their treatment planWhy “no pressure” conversations often build more trustHow to uncover barriers like cost, fear, or uncertainty earlyWhy patients should feel like partners in their treatmentHow starting small can lead to stronger long-term acceptanceListen now to learn how one simple shift in your treatment conversations can help patients feel clearer, safer, and more ready to move forward!‍Check out Sachin's Media:Website: https://www.thedentistmentor.co.uk/Email: sachin@thedentistmentor.co.ukInstagram: https://www.instagram.com/thedentistmentor/LinkedIn: https://www.linkedin.com/company/the-dentist-mentor/‍Host: Michael AriasJoin my newsletter: https://thedentalmarketer.lpages.co/newsletter/‍Join this podcast's Facebook Group: The Dental Marketer Society‍Love the Podcast? Follow on Your Favorite App! https://lnkfi.re/TDMPod

Metastatic breast cancer cannot be cured but it can be treated. Treatment focuses on disease management while maintaining the best possible quality of life. The unfortunate reality is that a treatment will only work for so long, then another one is needed. Joining us today are two women living with metastatic breast cancer who are sharing their experiences, living one treatment to the next. They are tireless advocates for research and the breakthroughs that will ensure their next treatment is available, when they need it. They're sharing how they live life to the fullest and manage their day-to-day care. Key Takeaways It's important to find hope while living treatment to treatment Recognize the physical and emotional toll of treatment, even when you look well Advocate for research, clinical trials, and discoveries that lead to better treatments Live in the present, prioritize quality of life, and give yourself grace Chapters 00:00 — Living with metastatic breast cancer 03:25 — The reality of treatment after treatment 07:45 — The emotional weight of uncertainty 13:23 — Why metastatic breast cancer research matters 26:34 — Living in the present and finding hope Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

Endometrial cancer cases are rising — and abnormal bleeding is the warning sign women should never ignore. Who is most at risk, why are more women being diagnosed, and what symptoms should prompt a call to your doctor?In this episode of Baptist Health Talk, host Sandra Peebles speaks with Dr. John Diaz, gynecological oncologist at the Herbert Wertheim Cancer Institute, about what women need to know about endometrial cancer, from early warning signs and risk factors to diagnosis, treatment and fertility-preserving options. Why endometrial cancer cases are increasing in the U.S. and around the world  How obesity and prolonged estrogen exposure can raise risk  The abnormal bleeding patterns women should report — including after menopause  Other warning signs such as pelvic pain, bloating and abnormal discharge  Why endometrial cancer can also affect younger women  How doctors diagnose endometrial cancer and why there is no routine screening test  Treatment options for early and advanced disease, including immunotherapy  When fertility-sparing treatment may be possible  How family history and Lynch syndrome can affect riskHost:Sandra PeeblesAward-Winning JournalistGuest:John P. Diaz, M.D.Chief of Gynecologic OncologyHerbert Wertheim Cancer InstituteChair, Obstetrics & Gynecology, FIUIf you found this episode helpful, we also recommend the following:Can Cervical Cancer Be Cured? A Gynecologic Oncologist AnswersEradicating Cervical Cancer: Possible or Impractical?

6 year old Miriam Koska was experiencing leg pain, abdominal pain, fevers, night sweats and fatigue in the fall of 2025 when she was diagnosed with an offshoot of Neuroblastoma known as Ganglioneuroblastoma. This form of Pediatric Cancer has a similar treatment protocol to the more well known Neuroblastoma. Miriam has been through difficult treatment but is doing as well as possible as she enters her next phase of treatment at the Mayo Clinic in Rochester, Minnesota.  

In this eye-opening episode of Bladder Cancer Matters, brought to you by the Bladder Cancer Advocacy Network, host Rick Bangs sits down with Todd Davey of Ferring Pharmaceuticals to pull back the curtain on something most patients never hear about: market access. What actually happens between a breakthrough therapy and the moment a patient can affordably receive it? Todd walks listeners through the strategy, value demonstration, and launch planning that determine whether innovative bladder cancer treatments—like ADSTILADRIN®—are covered by insurance and accessible without crushing out-of-pocket costs. It's a candid, behind-the-scenes look at how science, economics, and patient advocacy intersect—and why getting this right can mean fewer barriers, less financial stress, and more options for families facing bladder cancer. If you've ever wondered how new treatments move from the lab to real life, this episode will give you clarity—and a new appreciation for the complex work that helps turn innovation into access.

Welcome to the Oncology Brothers podcast! In this episode, we are joined by Dr. Aaron Gerds, a hematologist from the Cleveland Clinic, to discuss the current treatment algorithms for myeloproliferative neoplasms (MPNs), specifically focusing on polycythemia vera (PV) and essential thrombocythemia (ET).   Join us as we delved into: The diagnostic criteria for PV and ET, including the significance of JAK2 mutations and erythropoietin (EPO) levels The role of bone marrow biopsies in diagnosing and managing these conditions Treatment options for PV, including hydroxyurea, ropeginterferon alfa-2b, and ruxolitinib, as well as the approval of rusfertide The importance of risk stratification based on patient age and history of thrombosis The management of side effects associated with various treatment options The clinical utility of monitoring JAK2 allele burden and its implications for patient management Insights into the treatment landscape for ET, including the use of antiplatelet therapy and the role of acquired Von Willebrand disease   Whether you're a healthcare professional or someone interested in the latest advancements in oncology, this episode provides valuable insights into the complexities of managing PV and ET.   Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o    Follow us on social media: ⁠X/Twitter: https://x.com/oncbrothers  ⁠Instagram: https://www.instagram.com/oncbrothers  Website: https://oncbrothers.com/    Don't forget to like, subscribe, and hit the notification bell for more episodes on the latest in hematological and oncological care! #PolycythemiaVera, #EssentialThrombocythemia, #MPN, #JAK2, #OncologyBrothers

Why do so many chronic pain treatments provide temporary relief, only for the pain to return?In this episode of Beyond The Pain, Leigh Brandon speaks with Dr. Sean Altman about why persistent pain often requires a much broader approach than simply treating the area that hurts.After experiencing multiple injuries as a competitive ice hockey player—including concussions, migraines, vertigo and brain fog—Dr. Altman discovered the limitations of treating symptoms in isolation. His search for more complete answers led him to develop an approach he calls orthopedic functional medicine, combining traditional orthopedic care with functional medicine principles.Sean explains why the painful area is not necessarily where the problem began, how weaknesses or imbalances elsewhere in the body can contribute to injury, and why the nervous system may continue generating or amplifying pain after the original tissues have healed.You'll discover:• Why chronic pain treatments sometimes deliver only temporary relief• What orthopedic functional medicine means• Why the location of pain may not reveal its underlying cause• How different systems within the body influence one another• How chronic pain can change the nervous system• The role of neuromodulation, biofeedback and frequency-specific microcurrent• How manual therapy, laser therapy and shockwave therapy may support recovery• Why treatment must be personalised to create more durable results• What practitioners and patients can do to reduce the likelihood of pain returningIf you have tried multiple treatments without achieving lasting relief, this conversation may help you understand why—and show you a different way of approaching recovery.Listen now to discover why lasting change may require treating the whole person, not simply the painful body part.Please follow Beyond The Pain and share this episode with someone who may benefit from hearing it.Find Sean at:https://www.drseanaltman.com/https://www.linkedin.com/in/dr-sean-altman/https://www.facebook.com/sean.altman.9https://www.instagram.com/dr.sean.altman/https://www.facebook.com/profile.php?id=61576449047639Find Leigh at:Beyond the Pain - https://amzn.to/4y2HVWgBeyond The Pain ebook - https://amzn.to/4y0lH78 Beyond The Pain 14-Day Programme - https://bodychek.co.uk/beyond-the-pain-programme/Pain-Free Plate Free Guide - ⁠https://www.bodychek.co.uk/freepainguide/⁠Consult with Leigh - ⁠https://www.bodychek.co.uk/⁠consultation